Prospective study; Hypoxia imaging in lung cancer patients utilizing (18F)FAZA-PET/CT and 62Cu-ATSM PET/CT with reference to histopathology.

Prospective study; Hypoxia imaging in lung cancer patients utilizing (18F)FAZA-PET/CT and 62Cu-ATSM PET/CT with reference to histopathology. - Hypoxia imaging in lung cancer patients utilizing (18F)FAZA-PET/CT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015413

Enrollment

Registered

2014-10-18

Start date

2014-10-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The case who was diagnosed as primary lung cancer either pathologically or cytologically. 2) The case who was scheduled to receive a curative resection. 3) The case to whom iodine contrast media can be injected. 4) The case who gave the written consent to join the study. 5) The case whose PS is between 0 and 2, the case who suffers from a serious illness except malignancy and the case who will become pregnant.

Exclusion criteria

Exclusion criteria: 1) The case who is difficult to be included in the study due to psychological disorder and so on. 2) The case to whom the test agent cannot be injected due to iodine allergy and so on. 3) The case who is judged by the physician in charge not to be included in the study.

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
The accumulation of FAZA and ATSM at the tumor	—

Countries

Japan

Contacts

Public ContactMitsutomo Kohno

Department of Surgery, Keio University School of Medicine General thoracic surgery

kohno@a3.keio.jp0353633806

Outcome results